We examined the DNA and RNA of fresh leukemic cells (five patients) and long-term cultured T lymphocytes (four patients) from patients with adult T-cell leukemia for the presence of human T-cell leukemia virus (HTLV-I) sequences. In all cases HTLV-I previrus was found and several species of viral mRNAs were observed in all cell lines. We used HTLV DNA probes representing the gag, pol, and env genes and pX regions and the U3-and US-specific sequences to characterize the genetic content of the viral transcripts. Although similar RNA sequences were expressed in Om HTLV-I provirus-positive specimen of fresh primary leukemic cells, no viral transcripts were found in four other similar specimens. These findings are consistent with the idea that the expression of one or more HTLV-I genes may be involved in initiation of transformation, but consistent expression is not needed for maintaining the neoplastic state.
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The human T-cell leukemia virus, HTLV, represents a family of related, exogenous T-lymphotropic retroviruses. The HTLV-I subgroup is etiologically linked with adult T-cell leukemia-lymphoma (ATLL) (1), whereas HTLV-III is associated with the acquired immunodeficiency syndrome (AIDS) (2) (3) (4) (5) . A distantly related human T-cell virus, designated HTLV-II, has been isolated from one patient with a T-cell variant of hairy cell leukemia (6) (7) (8) and from one intravenous drug user with AIDS (9) . HTLV-I was first isolated from ATLL in two black U.S. patients (10, 11) . Subsequently, additional HTLV-I isolates have been obtained from several regions of the world (12) (13) (14) (15) . ATLL and HTLV-I infection are both endemic in southern Japan, the Caribbean, and Africa, and sporadic cases have been described in the U.S., Israel, South America, and Europe (12) (13) (14) (15) (16) (17) (18) . It is now apparent that most HTLV-I-associated neoplasias are typified by ATLL (19) and share many common features, such as frequent lymphadenopathy, hepatosplenomegaly, skin manifestations, hypercalcemia, and circulating large multinucleated lymphocytes. The predominant leukemic cell population usually displays markers (OKT4', OKT3 ) of mature T lymphocytes. Sera from almost all patients with ATLL contain antibodies against the major core proteins (p19, p24) and to cell surface membrane antigens of HTLV-I (16, 20, 21) . In all cases of ATLL tested to date, HTLV-I sequences have been found integrated in the genomic DNA of the fresh leukemic cells and the leukemic cells appear to be clonal expansions of single infected cells (14, 22) .
A number of HTLV-I genomes have been cloned (23, 24) and the complete nucleotide sequence of one of these has been determined (24) . In additional to the coding sequences for the gag, pol, and env proteins, a potential coding region (pX) located between the env gene and the 3' long terminal repeat (LTR) has been described (24) . HTLV-I does not have a cell-derived onc gene and might belong to the class of chronic leukemic viruses, which are the major subtype of leukemogenic retroviruses in nature. Paradoxically, both HTLV-I and HTLV-II efficiently immortalize normal cord blood T lymphocytes in vitro (12-15, 25, 26) .
The T-cell lines established from either cord blood cells after infection with HTLV-I in vitro or long-term cultured leukocytes of patients with ATLL are of monoclonal or oligoclonal derivation (14, 22) and share phenotypical features with the fresh uncultured leukemic cells. They differ from the normal lymphocytes in that they are immortalized and they require little or no exogenous T-cell growth factor (TCGF) for growth (15) . Therefore, HTLV-I appears to have the capacity to induce and maintain T-cell proliferation in vitro. However, although the fresh leukemic cells in most of the cases carry clonal chromosomal abnormalities, the primary and in vitro transformed cultured cells often contain a normal karyotype (27) . 
RESULTS

Detection of HTLV-I Provirus in the DNAs of the Fresh Leukemic Cells and in the Cultured Cells of Patients with
ATLL. Fresh leukemic T lymphocytes were obtained from the peripheral blood of five patients with ATLL. Two of the patients were Jamaican (OW, BT), two were Americans (HS, BF), and one was a Japanese emigrant to the U.S. (SD). This last case has been described in detail (30) . The T-cell lines were established (15) from the leukemic cells of three American patients (MJ, CR, MI) and one Israeli (UK). One part of the leukemic and cultured cell samples was used to extract cellular DNA and the remainder was used to extract cellular RNA. We used Southern blot analysis (31) to examine genomic DNA for the presence of HTLV sequences. All of these samples contain integrated HTLV proviruses, whereas DNA from numerous specimens of uninfected human cells is negative. Fig. 1 shows the hybridization of the DNAs of the five fresh samples and two of the cell lines with a probe (CR3L1) containing the U3 and R region (23) of the LTRs of HTLV. The genomic DNAs were cleaved with the restriction endonuclease EcoRI that does not cut within the HTLV genome. Therefore, the number of bands detected in this analysis reflects the number of viral copies infecting the monoclonal leukemic population. A single provirus is present in the first four fresh samples; two proviruses were present in one specimen from fresh leukemic cells (HS) (one of which is defective) and several in the DNAs from two of the cell lines. The higher provirus copy number in the cultured cells is a consistent finding and may reflect reinsertion of the provirus in culture.
Characterization of the Viral mRNAs in the Cultured Cells of Patients with ATLL. The RNAs extracted from the cultured lymphocytes were selected on oligo(dT)-cellulose, electrophoresed in denaturing conditions, and transferred to a specific GeneScreen membrane. The membranes were then hybridized with different HTLV subgenomic probes derived (32) with 32P-labeled HTLV probe LTR containing the U3 and R region of the LTR as described (23) .
by specific cleavage of the cloned HTLV genome. The HTLV-I probes used have been obtained as described in Materials and Methods and a schematic representation is depicted in Fig. 2 Upper. The results of hybridization of the cell line RNAs with the different HTLV probes are shown in Fig. 2 Lower, panels 1-4. The genetic content of the mRNA species in each cell line is represented on the side of each autoradiogram.
We detected several viral transcripts in all of the cell lines. All of the viral mRNA species hybridized with the LTR probe (see lane a of each panel) and with the U3-and U5-specific probes used separately (data not shown). A 9-kb mRNA hybridized to all probes used (panels 1-4, lanes a-e) and represents the genomic HTLV RNA. In addition to the 9-kb species, the gag fragment yielded mRNAs of 4.3, 3.8, and 4.3 kb in cell lines from patients MJ, MI, and UK, respectively. Such species hybridize also with env and pX probes but not with the pol probe (panels 1-3, lanes b-e) and must derive from a post-transcriptional processing of the HTLV genomic RNA. We believe that the sequences hybridizing in probe b are located prior to the donor splice site that is located at the 5' region of all of the animal retroviruses studied (33) (34) (35) (36) (37) . Since these mRNA species are the only ones that contain env sequences in MJ and UK RNA, they must encode for the envelope protein. The pol-specific fragment (probe c) hybridized only to the genomic read-through RNA. The lack of separate mRNAs that encode the gag precursor proteins and the viral polymerase indicates that such proteins must be encoded by the genomic RNA. This result is inconsistent with the finding of termination codons between the gag and pol genes (24) .
Using a pX-specific probe we detected a series of variable size abundant RNA transcripts in all four of the cell lines analyzed (panels 1-4, lane e) . Surprisingly, the sizes of these mRNAs (ranging from 3.2 to 3.8 kb) are bigger than the size Proc. Natl. Acad. Sci. USA 81 (1984) Proc. Natl. Acad. of the viral sequences contained in them. It is possible that these transcripts contain cellular sequences. In addition, a 2-kb mRNA containing the pX region is represented in low amounts in MI RNA (panel 2, lane e). Several mRNA transcripts are probably derived from defective virus genomes. These include a 2-kb gag-pX mRNA in MJ, a 4-kb gag-env mRNA in MI, and a 2-kb env-pX mRNA in UK and HUT 102 cells (see schemes in Fig. 2) .
Analysis of the RNAs Obtained from the Fresh Leukemic Cells. Viral transcripts were detected in one (SD) of the five cases of fresh leukemic cells. Several mRNA species from patient SD hybridized to the LTR probe (Fig. 3, panel 1 , lane a) as well as to the US-and U3-specific probes (not shown): a 9-kb genomic RNA, a 4-kb mRNA containing pX and env, a 3.2-kB mRNA, and a 2.0-kb mRNA hybridizing only to the pX region. The 3.2-kb mRNA is again bigger than its viral sequence content and, therefore, presumably also contains nonviral sequences. Surprisingly, the most abundant species is the 2.0-kb pX mRNA. Because the SD leukemic cells contained only one complete copy of HTLV in the genomic DNA (Fig. 1) , this transcript cannot be derived from a defective provirus containing only LTR and pX region. Therefore, this result suggests the existence of another acceptor splice site between env and pX and suggests that pX is a functional gene(s). The first splicing site would be located between the pol and env genes to generate the env-pX mRNA.
The RNAs of the other fresh HTLV DNA provirus-positive primary leukemic cells (Fig. 3, panel 2 ) failed to hybridize to any of the HTLV probes used. As a control for the quality of the RNAs the same filter was annealed with a plasmid probe (pDPO-1) containing the HLA class I gene (36) . The expected 1.6-kb HLA mRNA was detected in all four RNAs (panel 3). We, therefore, concluded that the failure to detect viral transcripts is not due to RNA degradation.
DISCUSSION
The lack of detection of viral transcripts in four of five fresh cells analyzed indicates that consistent expression of viral genes, including pX, might not be essential in the maintenance of the leukemic state.
Consistent with the frequent lack of expression of HTLV mRNA in fresh ATL cells is the earlier observation that expression of viral antigens is also restricted in uncultured ATLL cells (unpublished data). The presence of HTLV mRNAs in the leukemic cells of the patient SD correlates with the detection of the viral core antigen p24 by immunofluorescence in a small percentage of the leukemic cells (30) . Although the expression of viral mRNAs is restricted in the vast majority of the neoplastic cells in vivo that we analyzed, viral transcripts are always present in the longterm cultured leukocytes of patients with ATLL. A similar observation has been reported in the lymphocytic leukemia indUced by the bovine leukemia virus (BLV) in cattle, in which a plasma factor has also been identified that blocks the transcription of the BLV genome in the infected cells (37) . HTLV-I expression is always detected in the in vitro transformed T-cell lines obtained from normal cord blood (ref. 26 ; unpublished results). The majority of the primary neoplastic cell lines and the in vitro transformed T cells are immortalized and independent of exogenous TCGF. Studies on the expression of the TCGF gene in these cells showed no detectable expression of the gene in the mRNA (38) . It is possible that some viral encoded proteins (e.g., envelope or pX proteins) may confer selective advantage for cell proliferation in vitro by mimicking a growth factor. The selection of specific cell populations in vitro may correlate with the levels of virus expression in different infected cells. By analogy it is possible that a viral encoded protein may be needed in the early phase of the disease to induce cell proliferation. Active proliferation increases the chances for a mutation that may cause secondary leukemic conversion of one cell, which is then clonally expanded. The clonality of the leukemic cells in ATLL and the lack of expression of viral mRNAs in the majority of the fresh cells suggest an indirect mechanism in at least one of several stages of leukemogenesis, perhaps through the activation of cellular gene(s).
